000281115 001__ 281115
000281115 005__ 20250924102922.0
000281115 0247_ $$2doi$$a10.1007/s00259-025-07237-8
000281115 0247_ $$2pmid$$apmid:40140072
000281115 0247_ $$2pmc$$apmc:PMC12316748
000281115 0247_ $$2ISSN$$a1619-7070
000281115 0247_ $$2ISSN$$a1619-7089
000281115 037__ $$aDZNE-2025-01076
000281115 041__ $$aEnglish
000281115 082__ $$a610
000281115 1001_ $$00000-0002-0945-0724$$aBuchert, R.$$b0
000281115 245__ $$aCapacity for brain amyloid PET in Germany: Results from the 1st survey on nuclear brain imaging in Germany.
000281115 260__ $$aHeidelberg [u.a.]$$bSpringer-Verl.$$c2025
000281115 3367_ $$2DRIVER$$aarticle
000281115 3367_ $$2DataCite$$aOutput Types/Journal article
000281115 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1758629067_10849$$xLetter
000281115 3367_ $$2BibTeX$$aARTICLE
000281115 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000281115 3367_ $$00$$2EndNote$$aJournal Article
000281115 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x0
000281115 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000281115 7001_ $$0P:(DE-2719)2811239$$aDrzezga, A.$$b1$$eFirst author$$udzne
000281115 7001_ $$aSchreckenberger, M.$$b2
000281115 7001_ $$aMeyer, P. T.$$b3
000281115 7001_ $$aMedicine, Working Group Nuclear Brain Imaging of the German Society of Nuclear$$b4$$eCollaboration Author
000281115 773__ $$0PERI:(DE-600)2098375-X$$a10.1007/s00259-025-07237-8$$gVol. 52, no. 10, p. 3613 - 3617$$n10$$p3613 - 3617$$tEuropean journal of nuclear medicine and molecular imaging$$v52$$x1619-7070$$y2025
000281115 8564_ $$uhttps://pub.dzne.de/record/281115/files/DZNE-2025-01076%20SUP.docx
000281115 8564_ $$uhttps://pub.dzne.de/record/281115/files/DZNE-2025-01076.pdf$$yRestricted
000281115 8564_ $$uhttps://pub.dzne.de/record/281115/files/DZNE-2025-01076.pdf?subformat=pdfa$$xpdfa$$yRestricted
000281115 909CO $$ooai:pub.dzne.de:281115$$popenaire$$popen_access$$pVDB$$pdriver$$pdnbdelivery
000281115 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811239$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b1$$kDZNE
000281115 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x0
000281115 9141_ $$y2025
000281115 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-05
000281115 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-05
000281115 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-05
000281115 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000281115 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2024-12-05
000281115 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bEUR J NUCL MED MOL I : 2022$$d2024-12-05
000281115 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2024-12-05
000281115 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2024-12-05$$wger
000281115 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-05
000281115 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000281115 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2024-12-05
000281115 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bEUR J NUCL MED MOL I : 2022$$d2024-12-05
000281115 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-05
000281115 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2024-12-05
000281115 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-05
000281115 9201_ $$0I:(DE-2719)1011202$$kAG Boecker$$lPositron Emissions Tomography (PET)$$x0
000281115 980__ $$ajournal
000281115 980__ $$aVDB
000281115 980__ $$aUNRESTRICTED
000281115 980__ $$aI:(DE-2719)1011202
000281115 9801_ $$aFullTexts